JBIO (Jade Biosciences) Total Liabilities: $22.97 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $20.85
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences Total Liabilities?

Jade Biosciences JBIO +1.88% 12 Total Liabilities is $22.97 Mil as of Mar. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Jade Biosciences's Total Liabilities for the quarter that ended in Mar. 2026 was $22.97 Mil.

Jade Biosciences's quarterly Total Liabilities declined from Sep. 2025 ($23.10 Mil) to Dec. 2025 ($17.26 Mil) but then increased from Dec. 2025 ($17.26 Mil) to Mar. 2026 ($22.97 Mil).

Jade Biosciences's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2024 ($119.60 Mil) but then declined from Dec. 2024 ($119.60 Mil) to Dec. 2025 ($17.26 Mil).

Jade Biosciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences Total Liabilities Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
Total Liabilities
119.60 17.26

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial 0.00 22.41 23.10 17.26 22.97
JBIO
12GF Score
Jade Biosciences Inc JBIO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jade Biosciences's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=16.539+(0.724+2.2204460492503E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=17.26

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=349.781-332.518
=17.26

Jade Biosciences's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=22.292+(0.679+-1.5543122344752E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=22.97

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=319.433-296.462
=22.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $22.97 Mil mean?
Jade Biosciences (JBIO) has a Total Liabilities of $22.97 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Jade Biosciences and its competitors.
Is Jade Biosciences' Total Liabilities too high?
Jade Biosciences' current Total Liabilities is $22.97 Mil. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' Total Liabilities compare to AVLN and ARDX?
Jade Biosciences' Total Liabilities of $22.97 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Jade Biosciences and its competitors. Jade Biosciences's current Total Liabilities is $22.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current Total Liabilities of $22.97 Mil. The current Total Liabilities is $22.97 Mil. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current Total Liabilities is $22.97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.85
Price